ALEXANDRIA, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION, founded in 2013, is a community nonprofit in the Health Care sector that reported $4.7M in total revenue in fiscal year 2024. Revenue fell 81% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $1.3M, a strong 28% operating margin.
TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE.
GRANTS AND AWARDSTHE AASLD FOUNDATION RAISES FUNDS TO SUPPORT THE NEXT GENERATION OF REESARCHERS AND CLINICIAL EXPERTISE IN THE FIELD OF HEPATOLOGY. SPECIFICALLY, THE FOUNDATION FOCUSES ON PROGRAMS...
GRANTS AND AWARDSTHE AASLD FOUNDATION RAISES FUNDS TO SUPPORT THE NEXT GENERATION OF REESARCHERS AND CLINICIAL EXPERTISE IN THE FIELD OF HEPATOLOGY. SPECIFICALLY, THE FOUNDATION FOCUSES ON PROGRAMS THAT PROVIDE FUNDING TO SUPPORT CAREERS IN BASIC AND CLINICAL RESEARCH, WORKFORCE DEVELOPMENT PROGRAMS AND OPPORTUNITIES FOR EARLY-CAREER PROFESSIONALS TO ENGAGE WITH THE COMMUNITY:1. RESEARCH GRANTS: FUNDING INSTITUTIONS TO ADVANCE LIVER DISEASE RESEARCH.2. CLINICAL TRAINING AWARDS: SUPPORTING ADVANCED TRAINING FOR HEPATOLOGY FELLOWS, NURSE PRACTITIONERS, AND PHYSICIAN ASSISTANTS.3. WORKFORCE DEVELOPMENT PROGRAMS: PROGRAMS DEVELOPED TO SUPPORT AND MENTOR THOSE PURSUING CAREERS IN HEPATOLOGY RESEARCH AND CLINICAL PRACTICE. 4. ABSTRACT AWARDS: ENABLING EARLY CAREER INVESTIGATORS TO PRESENT PROMISING RESEARCH AT PREMIER HEPATOLOGY SCIENTIFIC MEETINGS, FOSTERING THE NEXT GENERATION OF LEADERS.
LIVER LEADER COUNCILTHE LIVER LEADER COUNCIL (LLC) IS A DYNAMIC CORPORATE PARTNERSHIP PROGRAM THAT ENGAGES INDUSTRY LEADERS THROUGH EXCLUSIVE BENEFITS, DISCOUNTS, AND STRATEGIC SUMMITS. HELD...
LIVER LEADER COUNCILTHE LIVER LEADER COUNCIL (LLC) IS A DYNAMIC CORPORATE PARTNERSHIP PROGRAM THAT ENGAGES INDUSTRY LEADERS THROUGH EXCLUSIVE BENEFITS, DISCOUNTS, AND STRATEGIC SUMMITS. HELD BIANNUALLY IN CONJUNCTION WITH DIGESTIVE DISEASE WEEK AND THE LIVER MEETING, LLC SUMMITS UNITE INDUSTRY, MEMBER-EXPERTS, REGULATORS, AND PATIENT ADVOCATES TO ADDRESS EMERGING CHALLENGES AND OPPORTUNITIES IN LIVER DISEASE, FOSTERING COLLABORATION AND INNOVATION.
EMERGING LIVER SCHOLARSTHE EMERGING LIVER SCHOLARS (ELS) PROGRAM, A JOINT INITIATIVE WITH AASLD, INSPIRES MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS WITH POTENTIAL FOR ACADEMIC MEDICINE TO PURSUE...
EMERGING LIVER SCHOLARSTHE EMERGING LIVER SCHOLARS (ELS) PROGRAM, A JOINT INITIATIVE WITH AASLD, INSPIRES MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS WITH POTENTIAL FOR ACADEMIC MEDICINE TO PURSUE HEPATOLOGY. BY PROVIDING MENTORSHIP AND EXPOSURE TO CUTTING-EDGE RESEARCH, THE ELS PROGRAM INVESTS IN THE FUTURE OF HEPATOLOGY, CULTIVATING PASSIONATE AND SKILLED PROFESSIONALS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,672,711 | $24,327,865 | -0.8% |
| Expenses | $3,354,407 | $4,082,172 | -0.2% |
| Net Income | $1,318,304 | $20,245,693 | -0.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KIMBERLY ANN BROWN | CHAIR | 5.00 |
Officer
Director
|
$15,000 | $0 | $15,000 |
| SAUL J KARPEN | VICE-CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| TAMAR H TADDEI | TREASURER | 5.00 |
Officer
Director
|
$0 | $0 | $30,000 |
| DAVID E BERNSTEIN | TRUSTEE | 5.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER LAI | TRUSTEE | 5.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL LUCEY | TRUSTEE | 5.00 |
Director
|
$0 | $0 | $0 |
| ROTONYA M CARR | TRUSTEE | 5.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW D'UVA | CHIEF EXECUTIVE OFFICER | 7.00 |
Officer
|
$0 | $109,073 | $746,906 |
| JULIE DEAL END 013125 | EXECUTIVE DIRECTOR | 25.00 |
Officer
|
$0 | $20,815 | $308,628 |
| MUKARAB ISLAM | VP, FINANCE AND ADMINISTRATION | 0.40 |
Officer
|
$0 | $36,139 | $232,239 |
| MARJORIE BYNUM | CHIEF OF STAFF | 2.50 |
Key Emp
|
$0 | $38,363 | $293,316 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $4,672,711 | $3,354,407 | $41,697,950 | $1,318,304 |
| 2024 | $24,327,865 | $4,082,172 | $39,519,282 | $20,245,693 |
| 2023 | $3,617,517 | $3,315,198 | $17,058,412 | $302,319 |
| 2022 | $1,331,021 | $2,347,891 | $16,329,501 | $-1,016,870 |
| 2021 | $3,045,289 | $3,842,724 | $19,536,229 | $-797,435 |
| 2020 | $4,205,172 | $3,858,751 | $18,288,127 | $346,421 |
| 2019 | $7,179,157 | $5,740,025 | $19,230,420 | $1,439,132 |
| 2018 | $3,958,679 | $6,094,684 | $16,713,149 | $-2,136,005 |
Compare AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION with other nonprofits in Virginia and across the country.